Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1282
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05655949 | Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio | ||
| NCT03203473 | Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) | ||
| NCT00431210 | Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma | ||
| NCT03761160 | Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy | ||
| NCT06488378 | Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer | ||
| NCT03057145 | Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors | ||
| NCT04627064 | ABEMA Alone or in COMBO With MK-6482 | ||
| NCT00006107 | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | ||
| NCT00004164 | Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx | ||
| NCT05403801 | STAMP+CBT mHealth for Cancer Pain | ||
| NCT00165334 | Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer | ||
| NCT00543114 | Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL | ||
| NCT05528263 | Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) | ||
| NCT02752009 | Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy | ||
| NCT00512889 | Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma | ||
| NCT01829217 | Sunitinib in Never-Smokers With Lung Adenocarcinoma | ||
| NCT02724878 | Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma | ||
| NCT04481672 | Intravenous Magnesium in Patients Receiving Cisplatin | ||
| NCT02448537 | A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas | ||
| NCT00085397 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | ||
| NCT02865135 | Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer | ||
| NCT04685915 | Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL | ||
| NCT06366347 | ALPINE: Maintenance Letrozole/Abemaciclib vs Pembrolizumab | ||
| NCT00268918 | Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients | ||
| NCT00856050 | Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma | ||
| NCT02756390 | CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors | ||
| NCT00137852 | Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer | ||
| NCT00165152 | Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing | ||
| NCT03613532 | Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN | ||
| NCT07027748 | Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma | ||
| NCT02666378 | Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer | ||
| NCT05463848 | Surgical Pembro +/- Olaparib w TMZ for rGBM | ||
| NCT00567359 | Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR | ||
| NCT03051659 | A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer | ||
| NCT05899361 | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest | ||
| NCT04789486 | Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer | ||
| NCT01112527 | PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma | ||
| NCT04751929 | Abemaciclib With or Without Atezolizumab for mCRPC | ||
| NCT00585637 | Vitamin D for Chemoprevention | ||
| NCT01368003 | STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling | ||
| NCT03422003 | Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma | ||
| NCT00670982 | Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer | ||
| NCT00658697 | Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer | ||
| NCT06153797 | A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors | ||
| NCT00142168 | CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia | ||
| NCT02158091 | A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL | ||
| NCT01890590 | A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma | ||
| NCT02282735 | Parental Decision-Making for Children With Relapsed Neuroblastoma | ||
| NCT02362997 | Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL | ||
| NCT00251394 | Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma |
